Canadian Institute For Knowledge Development
  • Register
  • Login

Canadian Journal of Medicine

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 1, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Indexing and Abstracting

Peer Review Process

News

Recent Developments of Diagnostic Criteria in Multiple Sclerosis

    Massoud Houshman Fawziah M. Mohammed

Canadian Journal of Medicine, 2019, Volume 1, Issue 1, Pages 20-28
10.33844/cjm.2019.60489

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

This review describes the more important developments of the neuroimaging of multiple
sclerosis (MS) in recent years, and provides a discussion of advanced MR imaging
techniques with regard to current findings, clinical correlations, and future directions. MS
pathology is originally defined by the presence of focal white matter lesions,
characterized by inflammatory/demyelinating, axonal loss, edema, blood brain barrier
break-down, and neurodegenerative processes that occur earlier in life, which usually
affects the gray and white matter, brainstem, cerebellum, spinal cord and optic nerve. In
recent years, the use of MRI techniques represents as a powerful tool to non-invasively
study different pathological substrates of lesions and microscopic tissue changes.
Techniques such as T2-weighted and gadolinium-enhanced T1-weighted MRI are very
sensitive in detecting lesions and, thus, increase the level of certainty of MS diagnosis.
In this review, we summarize the main evidence supporting the use of advanced MRI
techniques provide a better understanding of the neuropathologic processes that most
likely are related to disease activity and clinical progression in MS. Such metrics are able
to reveal a range of tissue changes that include inflammation, demyelination, axonal loss,
reactive glial scaring, neurodegeneration and neuroinflammation. In conclusion, MRI has
had a major impact on diagnosing MS, understanding the condition, and monitoring the
effects of clinical treatments
Keywords:
    Multiple sclerosis Magnetic resonance imaging Neuropathology Imaging Diagnosis Brain Spinal
  • PDF (410 K)
  • XML
(2020). Recent Developments of Diagnostic Criteria in Multiple Sclerosis. Canadian Journal of Medicine, 1(1), 20-28. doi: 10.33844/cjm.2019.60489
Massoud Houshman; Fawziah M. Mohammed. "Recent Developments of Diagnostic Criteria in Multiple Sclerosis". Canadian Journal of Medicine, 1, 1, 2020, 20-28. doi: 10.33844/cjm.2019.60489
(2020). 'Recent Developments of Diagnostic Criteria in Multiple Sclerosis', Canadian Journal of Medicine, 1(1), pp. 20-28. doi: 10.33844/cjm.2019.60489
Recent Developments of Diagnostic Criteria in Multiple Sclerosis. Canadian Journal of Medicine, 2020; 1(1): 20-28. doi: 10.33844/cjm.2019.60489
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 392
  • PDF Download: 191
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
Powered by eJournalPlus